Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79238 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Salbutamol EP Impurity C (Sulfate salt)
CAS :Formule :C13H21NO2H2O4SMasse moléculaire :223.32 : 98.073,7-Dihydro-3,7-dimethyl-6-[(5-oxohexyl)oxy]-2H-purin-2-one
CAS :Formule :C13H18N4O3Couleur et forme :NeatMasse moléculaire :278.31Pentoxifylline-d6
CAS :Produit contrôlé<p>Applications A labelled metabolite of Pentifylline. Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Phosphodiesterase inhibitor. Inhibits the synthesis of tumor necrosis factor α (TNF-α).<br>References Ward, A., et al.: Drugs, 34, 50 (1987), Samlaska, C.P., et al.: J. Am. Acad. Dermatol., 30, 603 (1994), Poulakis, et al.: Respir. Med., 93, 52 (1999), Reuter, et al.: Am J. Physiol., 277, 854 (1999),<br></p>Formule :C132H6H12N4O3Couleur et forme :NeatMasse moléculaire :284.34Bimatoprost Acid
CAS :Produit contrôlé<p>Applications Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost (B386820).Bimatoprost Acid is a metabolically stable analog of PGF2α (P838625) and is a potent agonist for the FP receptor.<br>References Balapure, A.K. et al.: Biochem. Pharmacol., 38, 2375 (1989); Hellberg, M.R. et al.: J. Ocular Pharmacol. Ther., 19, 97 (2003); Krishna, P.M. et al.: J. Pharm. res., 4, 2381 (2011);<br></p>Formule :C23H32O5Couleur et forme :White To Off-WhiteMasse moléculaire :388.50Glyoxal-bis-2,4-DNPH
CAS :Produit contrôléFormule :C14H10N8O8Couleur et forme :Dark OrangeMasse moléculaire :418.282,2,2-Trifluoroethyl 2,5-Bis(2,2,2-trifluoroethoxy)benzoate
CAS :Produit contrôlé<p>Applications Intermediate in the production of antiarrhythmic N-(Piperidylalkyl)trifluoroethoxybenzamides. Possible Flecainide impurity.<br>References Banitt, E., et al.: J. Med. Chem., 20, 821 (1977),<br></p>Formule :C13H9F9O4Couleur et forme :NeatMasse moléculaire :400.19Didecyl Dimethyl Ammonium Chloride
CAS :<p>Applications Didecyl Dimethyl Ammonium Chloride is a compound that exhibits some fungacidal and antimirobial functions.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kanazawa, A. et al.: Antimicrob. Agents Chemother., 38, 945 (1994)l; Schultz, T.P. et al.: Phytochem., 54, 47 (2000);<br></p>Formule :C22H48N·ClCouleur et forme :Light Beige To BrownMasse moléculaire :362.082-Oxo Clopidogrel Hydrochloride(Mixture of Diastereomers)
CAS :Produit contrôlé<p>Applications The essential intermediate metabolite from which the active metabolite of Clopidogel is formed.<br>References Feliste, R., et al.: Thromb. Res., 48, 403 (1987), Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Herbert, J., et al.: Cardiovasc Drug. Rev., 11, 180 (1993), Sugidachi, A., et al.: B. J. Pharmacol., 132, 47 (2001)<br></p>Formule :C16H17Cl2NO3SCouleur et forme :NeatMasse moléculaire :374.28Trandolaprilat Monohydrate
CAS :<p>Applications A metabolite of Trandolapril, an antihypertensive.<br>References Blankley, C.J., et al.: J. Med. Chem., 30, 992 (1987)<br></p>Formule :C22H30N2O5·H2OCouleur et forme :Off White PowderMasse moléculaire :420.50N1-Acetyl Triethylenetetramine Trihydrochloride
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications N1-Acetyl Triethylenetetramine is a monoacetylated metabolite of the selective CuII-chelator Triethylenetetramine (T776630).<br>References Murata, Y. et al.: Biomed. Res. Trace Elem., 4, 185 (1993): Lu, J. et al.: J. Clin. Pharmacol., 50, 647 (2010); Lu, J. et al.: J. Chrom. B Anal. Technol. Biomed. Life Sci., 859, 62 (2007);<br></p>Formule :C8H23Cl3N4OCouleur et forme :NeatMasse moléculaire :297.651-(3-Hydroxypropyl)theobromine
CAS :Produit contrôléFormule :C10H14N4O3Couleur et forme :White To Off-WhiteMasse moléculaire :238.2434-(2-Aminophenyl)-3-morpholinone
CAS :<p>Applications 4-(2-Aminophenyl)-3-morpholinone is a reagent used in the preparation of various Morpholine based pharmaceuticals.<br>References Mederski, W., et al.: Bioorg. Med. Chem. Lett., 14, 3763 (2004), Roehrig, S., et al.: J. Med. Chem., 48, 5900 (2005),<br></p>Formule :C10H12N2O2Couleur et forme :Off White SolidMasse moléculaire :192.2141,1'-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis[Theobromine]
CAS :Formule :C26H34N8O5Couleur et forme :NeatMasse moléculaire :538.604,6-Dihydroxypyrazolo[3,4-d]pyrimidine
CAS :Produit contrôlé<p>Stability Hygroscoipic<br>Applications 4,6-Dihydroxypyrazolo[3,4-d]pyrimidine is a major metabolite of Allopurinol (A547300). It is a xanthine oxidase inhibitor.<br>References Pacher, P., et al.: Pharmacol. Rev., 58, 87 (2006); Marro, P., et al.: Brain Res., 650, 9 (1994); Abramov, A., et al.: J. Neurosci., 27, 1129 (2007); Day, R., et al.: Clin. Pharmacokinet., 46, 623 (2007);<br></p>Formule :C5H4N4O2Couleur et forme :Off White SolidMasse moléculaire :152.11Methylamine (2M in THF)
CAS :Produit contrôlé<p>Applications Methylamine is a common chemical reagent used in the synthesis of 2-aminoquinolines as potent and selective inhibitors of neuronal nitric oxide synthase for neurodegenrative disorders.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cinelli, M. et al.: J. Med. Chem., 58, 8694 (2015);<br></p>Formule :CH5NCouleur et forme :Single SolutionMasse moléculaire :31.06Febuxostat-d9
CAS :Produit contrôlé<p>Applications Labelled Febuxostat (F229000). Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout.<br>References Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993), Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003), Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005), Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005),<br></p>Formule :C16D9H7N2O3SCouleur et forme :NeatMasse moléculaire :325.43Iopromide
CAS :<p>Applications Nonionic, injectable radio-contrast medium. Diagnostic aid (radiopaque medium).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Muetzel, W., et al.: Am.J. Neuroradiol., 4, 350 (1983), Dawson, P., et al.: Acta Radiol. Diagn., 25, 253 (1984),<br></p>Formule :C18H24I3N3O8Couleur et forme :NeatMasse moléculaire :791.11N-Demethylivabradine
CAS :Produit contrôléFormule :C26H34N2O5Couleur et forme :Light Brown To BrownMasse moléculaire :454.56Riociguat-13C-d3
CAS :Produit contrôlé<p>Applications Riociguat-13C-d3 is the labelled analogue of Riociguat (R520000), which is used in the treatment for pulmonary hypertension.<br>References Frey, R. et al.: J. Clin. Pharmacol., 51, 1051 (2011);<br></p>Formule :C1913CH16D3FN8O2Couleur et forme :NeatMasse moléculaire :426.43Leflunomide-d4
CAS :Produit contrôlé<p>Applications An immunosuppressive. Inhibits T and B cell proliferation. Activity is attributed mainly to its metabolite, a malononitrile derivative, which is beleived to inhibit dihydroorotate dehydrogenase as well as several protein tyrosine kinases.This compound is suitable for dihydroorotate dehydrogenase (DHODH) related research.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Vrenken, T., et al.: J. Hepatol., 49, 799 (2008), Mazzucco, G., et al.: Clin. Nephrol., 70, 163 (2008), Davies, M., et al.: J. Med. Chem., 52, 2683 (2009),<br></p>Formule :C12D4H5F3N2O2Couleur et forme :NeatMasse moléculaire :274.23Bosentan
CAS :Produit contrôléFormule :C27H29N5O6SCouleur et forme :Off WhiteMasse moléculaire :551.61Ramiprilat-d5 (Mixture of Diastereomers)
CAS :Produit contrôlé<p>Applications A labelled metabolite of Ramipril (R111000).<br>References Teetz, V., et al.: Arzneim.-Forsch., 34, 1399 (1984), Ruggenenti, P., et al.: Lancet, 352, (1998), Bosch, J., et al.: Br. Med. J., 324, 1 (2002),<br></p>Formule :C212H5H23N2O5Couleur et forme :NeatMasse moléculaire :393.49Treprostinil Ethyl Ester
CAS :Produit contrôléFormule :C25H38O5Couleur et forme :NeatMasse moléculaire :418.566N-Demethyl Ivabradine Hydrochloride
CAS :Produit contrôléFormule :C26H34N2O5·ClHCouleur et forme :NeatMasse moléculaire :491.02Boc-L-Nitroarginine
CAS :Produit contrôlé<p>Applications Boc-L-Nitroarginine, can be used in peptide chemistry. It has been also shown to act as NO synthase inhibitor, and thus used in the study of The effects of methylene blue (MB) for treatment of sepsis induced by bowel perforation.<br>References Galili, Y. Euro. surg. Rese. vol. 29, P:390-395 (19997);<br></p>Formule :C11H21N5O6Couleur et forme :NeatMasse moléculaire :319.31Bimatoprost
CAS :<p>Stability Light Sensitive<br>Applications Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.<br>References Brandt, J.D., et al.: Ophthalmology, 108, 1023 (2001), Woodward, D.F., et al.: J. Pharmacol. Exp. Ther., 305, 772 (2003), Quinones, R., et al.: J. Ocul. Pharmacol. Ther., 20, 115 (2004),<br></p>Formule :C25H37NO4Couleur et forme :WhiteMasse moléculaire :415.57A77 1726-d4
CAS :Produit contrôlé<p>Applications The active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function.<br>References Kirsch, B.M., et al.: Arthritis Research and Therapy, 7, 3, R694, (2005)<br></p>Formule :C122H4H5F3N2O2Couleur et forme :Off-WhiteMasse moléculaire :274.23S-(-)-Warfarin
CAS :Produit contrôlé<p>Applications The S-(-)-form of Warfarin (W498500). Coumarin anticoagulant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hagan, E.C., et al.: J. Am. Pharm. Assoc. Sci. Ed., 42, 379 (1953), Bell, R.G., et al.: Biochemistry, 11, 1959 (1972), Valente, J.E., et al.: J. Med. Chem., 20, 1489 (1977), Back, N., et al.: Pharmacol. Res. Commun., 10, 445, (1978), Babhair, S.A., et al.: Anal. Profiles Drug Subs., 14, 423 (1985), Takahashi, H., et al.: Echizen, Clin. Pharmacokinet., 40, 587 (2001),<br></p>Formule :C19H16O4Couleur et forme :White SolidMasse moléculaire :308.33Trandolapril Diketopiperazine
CAS :Produit contrôlé<p>Impurity Trandolapril EP Impurity D<br>Applications Trandolapril Diketopiperazine (Trandolapril EP Impurity D) is a metabolite of the antihypertensive Trandolapril (Ru44570) (T713500), an angiotensin-converting enzyme inhibitor.<br>References Bakshi, M., et al.: J. Pharm. Biomed. Anal., 28, 1011 (2002), Cedrowska, I., et al.: Acta Pol. Pharm., 60, 141 (2003), Singh, S., et al.: J. Pharm. Biomed. Anal., 41, 1037 (2006),<br></p>Formule :C24H32N2O4Couleur et forme :NeatMasse moléculaire :412.52Levosimendan
CAS :<p>Applications Bioactive enantiomer of racemate, Simendan. Positive inotropic agent with vasodilating activity. Cardiotonic.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995), Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996),<br></p>Formule :C14H12N6OCouleur et forme :Yellow To Dark YellowMasse moléculaire :280.28Iomeprol-d3
CAS :Produit contrôlé<p>Applications Diagnostic aid (radiopaque medium).<br>References Gallotti, A., et al.: Eur. J. Radiol., 18, Suppl 1 S1(1994), Morisetti, A., et al.: Eur. J. Radiol., 18, Suppl 1 S21(1994).<br></p>Formule :C17H19D3I3N3O8Couleur et forme :Off-WhiteMasse moléculaire :780.10Argatroban monohydrate
CAS :Produit contrôléFormule :C23H36N6O5S·H2OCouleur et forme :NeatMasse moléculaire :526.65Ivermectin B1a-D2
CAS :Produit contrôlé<p>Applications Ivermectin B1a-D2 is a deuterium labelled analogue of Ivermectin B1a (I940815), which is a major component of Ivermectin (I940800), a semi-synthetic derivative of Abamectin; consists of a mixture of not less than 80% component B1a and not more than 20% component B1b. Antihelmintic (Onchocerca). An invitro inhibitor of SARS-CoV-2/ Covid-19.<br>References Chabala, J.C., et al.: J. Med. Chem., 23, 1134 (1980); Campbell, W.C., et al.: Science, 221, 823 (1983); Bennett, J.L., et al.: Parasitol. Today, 4, 226 (1988); Plaisier, A.P., et al.: J. Infect. Dis., 172, 204 (1995);; Caly, L., et al.: Antivir. Res., 178<br></p>Formule :C48H72D2O14Couleur et forme :NeatMasse moléculaire :877.115-Methylisoxazole-4-carboxylic Acid
CAS :Produit contrôléFormule :C5H5NO3Couleur et forme :NeatMasse moléculaire :127.10Apixaban PG Ester-I
CAS :Produit contrôlé<p>Applications Apixaban PG Ester-I is one of the multiple constituents extracted from Biebersteinia multifida, that exhibits inhibitory activity on acetylcholinesterase.<br>References Xiang, F., et al.: Faming Zhuanli Shenqing (2019), CN 109432093 A 20190308.<br></p>Formule :C28H30N4O6Couleur et forme :NeatMasse moléculaire :518.56Dofetilide N-Oxide
CAS :Produit contrôléFormule :C19H27N3O6S2Couleur et forme :NeatMasse moléculaire :457.56Brinzolamide
CAS :Produit contrôlé<p>Applications Carbonic anhydrase inhibitor. Antiglaucoma agent.<br>References Silver, L.H., et al.: Am. J. Ophthalmol., 126, 400 (1998), Davies, N., et al.: Clin. Exp. Pharmacol. Physiol., 27, 558 (2000), Stave, J., et al.: Ophthalmologe, 99, 276 (2002),<br></p>Formule :C12H21N3O5S3Couleur et forme :NeatMasse moléculaire :383.51Diclofenac Levomenthol Ester
CAS :Produit contrôléFormule :C24H29Cl2NO2Couleur et forme :NeatMasse moléculaire :434.399Tolvaptan
CAS :Produit contrôlé<p>Applications Tolvaptan is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000); Udelson, J., et al.: Circulation, 104, 2417 (2001); Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005); Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006);<br></p>Formule :C26H25ClN2O3Couleur et forme :White To Off-WhiteMasse moléculaire :448.94Ramiprilat Acyl-β-D-glucuronide >65%
CAS :Produit contrôléFormule :C27H36N2O11Degré de pureté :>65%Couleur et forme :NeatMasse moléculaire :564.58Allopurinol-d2
CAS :Produit contrôlé<p>Applications Labelled xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978), Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005), Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005),<br></p>Formule :C52H2H2N4OCouleur et forme :Light BrownMasse moléculaire :138.12Repaglinide
CAS :Produit contrôlé<p>Applications Non-sulfonylurea oral hypoglycemic agent. Used as an antidiabetic.<br>References Wolffenbuttel, B.H.R., et al.: Eur. J. Clin. Pharmacol., 45, 113 (1993), Ampudia-Blasco, F.J., et al.: Diabetologia, 37, 703 (1994),<br></p>Formule :C27H36N2O4Couleur et forme :White To Off-WhiteMasse moléculaire :452.59Cyclosporin B
CAS :<p>Applications An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.<br>References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),<br></p>Formule :C61H109N11O12Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1188.584-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone
CAS :Produit contrôlé<p>Impurity Rivaroxaban Impurity E<br>Applications 4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone (Rivaroxaban Impurity E) is an impurity of Rivaroxaban (R538000), which is a antithrombotic agent and a FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formule :C13H17ClN2O3Couleur et forme :NeatMasse moléculaire :284.74Pentoxifylline
CAS :Produit contrôléFormule :C13H18N4O3Couleur et forme :White To Off-WhiteMasse moléculaire :278.31Ramipril Acyl-β-D-glucuronide
CAS :Produit contrôlé<p>Applications A metabolite of Ramipril (R111000). This compound is not stable in an aqueous solution.<br></p>Formule :C29H40N2O11Couleur et forme :NeatMasse moléculaire :592.63Febuxostat
CAS :<p>Applications Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.<br>References Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993), Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003), Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005), Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005),<br></p>Formule :C16H16N2O3SCouleur et forme :White To Off-WhiteMasse moléculaire :316.37(15S)-Latanoprost
CAS :<p>Impurity Latanoprost USP Related Compound B<br>Applications An impurity of commercially prepared Latanoprost (L177280). Latanoprost USP Related Compound B.<br>References Resul, B., et al.: J. Med. Chem., 36, 2242 (1993),<br></p>Formule :C26H40O5Couleur et forme :ColourlessMasse moléculaire :432.596-Hydroxy Warfarin β-D-Glucuronide D Disodium Salt Hydrate
CAS :Produit contrôlé<p>Applications 6-Hydroxy Warfarin β-D-Glucuronide Disodium Salt Hydrate, is a metabolite of Warfarin (W498500) in humans.<br>References Barbato, F., et al.: J. Pharm. Sci., 86, 225 (1997), Kavana, M., et al.: Biochemistry, 42, 10238 (2003), Franco, A., et al.: Environ. Toxicol. Chem., 28, 458 (2009),<br></p>Formule :C25H22Na2O11•xH2OCouleur et forme :NeatMasse moléculaire :544.421802Apixaban PG Ester-II
CAS :Produit contrôlé<p>Applications Apixaban PG Ester-II is one of the multiple constituents extracted from Biebersteinia multifida, that exhibits inhibitory activity on acetylcholinesterase.<br>References Xiang, F., et al.: Faming Zhuanli Shenqing (2019), CN 109432093 A 20190308.<br></p>Formule :C28H30N4O6Couleur et forme :NeatMasse moléculaire :518.56(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
CAS :Produit contrôlé<p>Applications A metabolite of Levosimendan.<br>References Rubinstein, A., et al.: J. Pharmacol. Met., 19, 213 , (1988), Pollesello, P., et al.: J. Biol. Chem., 269, 28584 (1994), Yokoshiki, H., et al.: Eur. J. Pharmacol., 333, 249 (1997)<br></p>Formule :C11H13N3OCouleur et forme :NeatMasse moléculaire :203.24Allopurinol-13C,15N2
CAS :Produit contrôlé<p>Applications Allopurinol-13C,15N2, is the labeled analogue of Allopurinol (A547300), acting as an Xanthine oxidase inhibitor, and used in treatment of hyperuricemia and chronic gout.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978), Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005), Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005),<br></p>Formule :C413CH4N215N2OCouleur et forme :NeatMasse moléculaire :139.09Febuxostat-d7
CAS :Produit contrôlé<p>Applications Febuxostat-d7, is the labeled analogue of Febuxostat-d7 (F229000), a Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout.<br>References Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993), Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003), Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005), Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005),<br></p>Formule :C16H9D7N2O3SCouleur et forme :NeatMasse moléculaire :323.427-Hydroxy Warfarin-d5
CAS :Produit contrôlé<p>Applications A labelled metabolite of Warfarin (W498500) in humans.<br>References Barbato, F., et al.: J. Pharm. Sci., 86, 225 (1997), Kavana, M., et al.: Biochemistry, 42, 10238 (2003), Franco, A., et al.: Environ. Toxicol. Chem., 28, 458 (2009),<br></p>Formule :C192H5H11O5Couleur et forme :NeatMasse moléculaire :329.362-Chloro-N-phenylacetamide
CAS :Produit contrôlé<p>Applications 2-Chloro-N-phenylacetamide is used as a reagent in the synthesis of indolylmethylene benzo[h]thiazolo[2,3-b]quinazolinones which exhibit anticancer and antimicrobial activities in vitro.<br>References Gali, R., et al.: Bioorg. Med. Chem. Lett., 24, 4239 (2014)<br></p>Formule :C8H8ClNOCouleur et forme :NeatMasse moléculaire :169.03Eltrombopag Ethyl Ester
Produit contrôlé<p>Applications Eltrombopag Ethyl Ester, is a metabolite of Eltrombopag (E508000), which is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia.<br>References Bussel, J., et al.: New Eng. J. Med., 357, 2237 (2007), Marsilje, T., et al.: Bioorg. Med. Chem. Lett., 18, 5259 (2008), Alper, P., et al.: Bioorg. Med. Chem. Lett., 18, 5255 (2008),<br></p>Formule :C27H26N4O4Couleur et forme :NeatMasse moléculaire :470.52Diethyl Phthalate
CAS :<p>Applications A phthalate metabolite with genotoxic effect. This compound is a contaminant of emerging concern (CECs).<br>References Reyes, F., et al.: J. Clin. Endocrinol. Metab., 37, 74 (1973), Engel, S., et al.: Neurotoxicology, 30, 522 (2009),<br></p>Formule :C12H14O4Couleur et forme :ColourlessMasse moléculaire :222.24Levosimendan Triazene Impurity
CAS :<p>Stability Light Sensitive<br>Applications Levosimendan Triazene is an impurity of Levosimendan (L378000); a positive inotropic agent with vasodilating activity. Also cardiotonic.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995); Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996)<br></p>Formule :C22H23N7O2Couleur et forme :NeatMasse moléculaire :417.46N-(4-(N-carbamoylsulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide
Formule :C15H17N5O4SMasse moléculaire :363.393-Descyano-3-formyl Febuxostat
CAS :Formule :C16H17NO4SCouleur et forme :NeatMasse moléculaire :319.38Bispyrazolone
CAS :<p>Applications Bispyrazolone is an impurity of Edaravone (E335000).<br></p>Formule :C20H18N4O2Couleur et forme :NeatMasse moléculaire :346.385,6-trans Travoprost
CAS :<p>Applications An 5,6-trans isomeric impurity of the selective FP prostaglandin receptor agonist Travoprost (T715600).<br></p>Formule :C26H35F3O6Couleur et forme :NeatMasse moléculaire :500.551-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid
CAS :Formule :C25H24N4O5Couleur et forme :Light Orange ColourMasse moléculaire :460.48
![3,7-Dihydro-3,7-dimethyl-6-[(5-oxohexyl)oxy]-2H-purin-2-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD448890.webp&w=3840&q=75)
![1,1'-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis[Theobromine]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM270000.webp&w=3840&q=75)
![4,6-Dihydroxypyrazolo[3,4-d]pyrimidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD454550.webp&w=3840&q=75)
![4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC292820.webp&w=3840&q=75)
![6'-Methoxy-[3,3'-bipyridin]-6(1H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-P219037.webp&w=3840&q=75)
![1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]p…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM266420.webp&w=3840&q=75)